Jamshed J. Dalal
Mumbai, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Retrospective Observational Electronic Medical Records-based Real World Study to Assess the Prevalence and Treatment of Dyslipidemia in Indian Patients.
Journal: The Journal of the Association of Physicians of India
Published: November 24, 2025
Beyond Amlodipine-The Case for S-amlodipine as the First Choice Calcium Channel Blocker: An Expert Opinion from India.
Journal: The Journal of the Association of Physicians of India
Published: April 09, 2025
Position of Beta-blockers in the Treatment of Hypertension Today: An Indian Consensus.
Journal: The Journal of the Association of Physicians of India
Published: October 11, 2024
Indian Experience with Vericiguat: A Review Based upon Case Series.
Journal: The Journal of the Association of Physicians of India
Published: October 11, 2024
Telmisartan Plus Amlodipine as the Preferred Initial Combination in Newly Diagnosed Indian Patients with Hypertension: An Expert Consensus Statements.
Journal: The Journal of the Association of Physicians of India
Published: May 13, 2024
Consensus on Current Landscape and Treatment Trends of Obesity in India for Primary Care Physicians.
Consensus on Current Landscape and Treatment Trends of Obesity in India for Primary Care Physicians.
Journal: The Journal of the Association of Physicians of India
Published: May 08, 2024
CSI clinical practice guidelines for dyslipidemia management: Executive summary.
Journal: Indian heart journal
Published: December 05, 2023
Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV.
Journal: Journal of clinical lipidology
Published: November 16, 2023
Clinical and Demographic Characteristics of Patients with Coexistent Hypertension, Type 2 Diabetes Mellitus, and Dyslipidemia: A Retrospective Study from India.
Journal: Drugs - real world outcomes
Published: October 10, 2023
Cardiovascular Compatibility of Proton Pump Inhibitors: Practice Recommendations.
Journal: Cardiology and therapy
Published: August 24, 2023
Prevalence of cardiac abnormalities and heart failure in unselected out-patients with type 2 diabetes mellitus and associated clinical factors: Real-world evidence from an Indian registry.
Journal: Indian heart journal
Published: July 28, 2023
Last Updated: 09/26/2026